Company intelligence / Profile preview

SERO

Billingstad, Akershus, Norway
Ownership
Private
Development stage
Other
01

Overview

SERO is a Norwegian in vitro diagnostics and laboratory quality company focused on developing, manufacturing, and marketing independent quality control materials for medical laboratories. Founded in 1963, the company specializes in QC products used in clinical chemistry and immunochemistry to help laboratories generate reliable and comparable test results. Its best-known product family includes Seronorm and related control materials covering analytes such as hormones, cardiac markers, tumor markers, diabetes markers, trace elements, lipids, drugs, and other laboratory medicine parameters. SERO operates an ISO 13485-certified facility near Oslo and exports the majority of its products to more than 60 countries through direct sales in the Nordics and distributor networks internationally. The company is not a therapeutics developer; it is a commercial diagnostics tools and controls business serving clinical labs and IVD partners.

Modalities
Device
Industry
Protein Biomarker Diagnostics
02

Partnerships

Global distributor network for laboratory and IVD markets

Beyond the preview

Go deeper on SERO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SERO.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call